HUM vs TRT · P/E 39, rev $117.76B vs P/E 294, $148.7M cap
Humana Inc (HUM) versus Trio-Tech International (TRT) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Trio-Tech International (TRT) is a semiconductor equipment & materials company listed on AMEX.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
TRT does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TRT currently screens at market cap $148.7M and trailing P/E 294.0.
Not investment advice. Open the HUM and TRT stock pages for the full models.
Not investment advice.